← Mechanisms of action
IL5
SINGLE PROTEINHomo sapiens
Preferred name: Interleukin-5 ChEMBL ↗
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| il-5 car-t cells | Immunity, passive | experimental | Cell therapy | IL5 immunity, passive |
| 610 | Inhibitor | experimental | mAb | IL5 inhibitor |
| bbt002 | Inhibitor | experimental | mAb | IL5 inhibitor |
| CSL311 | Inhibitor | experimental | mAb | IL5 inhibitor |
| depemokimab (Exendsur) | Inhibitor | approved | mAb | Interleukin-5 inhibitor |
| mepolizumab (Nucala) | Inhibitor | approved | mAb | IL5 inhibitor |
| reslizumab (cinqair) | Inhibitor | approved | mAb | IL5 inhibitor |
| suplatast tosylate | Inhibitor | experimental | Small molecule | IL5 inhibitor |